Document is current
Any future updates will be listed below
-
Authors
Murphy, Rory
Martin, Keith R. https://orcid.org/0000-0002-9347-3661
- License Information
-
More Information
Article History
Received: 1 January 2024
Revised: 22 July 2024
Accepted: 22 October 2024
First Online: 8 November 2024
Competing interests
: KRM is a co-founder of three companies developing gene therapies for eye disease: Quethera (Astellas), Ikarovec and Mirugen. RM declares no potential conflict of interest.
